Assessment of circulating tumor (ct) DNA in patients (pts) with locally advanced rectal cancer (LARC) treated with neoadjuvant therapy (NAT) Published Date October 27, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen